GO:0035189 Rb-E2F complex: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0035189 (Rb-E2F complex) is a cellular component defined as a multiprotein complex containing a heterodimeric E2F transcription factor and a Retinoblastoma (Rb) family member that represses transcription of E2F-regulated genes to control cell cycle progression.
• The complex is a central node of the p53-p21-RB signaling axis that enforces cell cycle checkpoints and can trigger senescence.
• Rb-E2F repressor complexes are related to but distinct from DREAM/MuvB complexes, and together they coordinate cell cycle gene expression.
• The complex recruits chromatin modifiers such as HDACs and Mediator subunits (e.g., MED13L) to repress transcription and induce growth arrest [5,7].
• Dysregulation of Rb-E2F complexes is implicated in cancer, melanocytic biology, senescence, and viral persistence [4,6,7].
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal dissection of Rb-E2F complex components in cell cycle and disease research.
Description
The Rb-E2F complex (GO:0035189) is a multiprotein cellular component that contains a heterodimeric E2F transcription factor and a Retinoblastoma (Rb) family member. It is capable of repressing transcription of E2F-regulated genes in order to regulate cell cycle progression. This complex is a key effector of the p53-p21-RB signaling pathway, which controls cell cycle checkpoints and senescence. The Rb-E2F complex is closely related to the DREAM/MuvB complex, and together these complexes coordinate gene expression during the cell cycle. Because E2F target genes drive DNA replication and mitosis, the Rb-E2F complex acts as a brake on proliferation, and its dysregulation is a hallmark of many cancers. Researchers study GO:0035189 to understand how cells decide between proliferation, quiescence, and senescence, and to identify therapeutic targets in cancer and other diseases [1,6].
Rb-E2F complex At A Glance
| GO ID | GO:0035189 |
|---|---|
| GO term | Rb-E2F complex |
| Ontology | cellular_component |
| Synonym | retinoblastoma-E2F complex |
| Major function | Repression of E2F-regulated genes to regulate cell cycle progression |
| Related complex | DREAM/MuvB complex |
| Key components | E2F transcription factors, DP subunits, Rb family proteins (RB1, RBL1, RBL2) |
| Associated co-repressors | HDACs, Mediator subunit MED13L [5,7] |
| Disease relevance | Cancer, senescence, viral persistence [4,6,7] |
What Is GO:0035189?
The Rb-E2F complex is a multiprotein assembly that includes a heterodimeric E2F transcription factor (typically E2F and DP subunits) bound to a Retinoblastoma (Rb) family protein (such as RB1, RBL1/p107, or RBL2/p130). This complex binds to E2F sites in DNA and represses transcription of E2F-regulated genes, thereby regulating cell cycle progression. It is a cellular component that functions as a transcriptional repressor module, often recruiting additional co-repressors such as histone deacetylases (HDACs) and Mediator subunits [5,7].
Why Is Rb-E2F complex Important in Cell Biology?
The Rb-E2F complex is essential for proper cell cycle control, acting as a transcriptional repressor that prevents inappropriate entry into S phase. Its dysregulation leads to uncontrolled proliferation, a hallmark of cancer, and it is a critical node in the p53-p21-RB tumor suppressor network. Understanding the Rb-E2F complex also illuminates mechanisms of senescence, differentiation, and viral infection, making it a high-value target for basic and translational research [4,6,7].
• Controls cell cycle progression by repressing E2F target genes.
• Central to the p53-p21-RB tumor suppressor pathway.
• Coordinates gene expression with the DREAM/MuvB complex during the cell cycle.
• Recruits HDACs and Mediator subunits to modulate chromatin and transcription [5,7].
• Implicated in melanocytic system biology and melanoma.
• Plays a role in cellular senescence through repression of mitotic and DNA repair genes.
• Involved in interferon-induced repression of adenovirus for persistent infection.
• Provides a mechanistic basis for understanding how cells exit the cell cycle.
• Serves as a target for cancer therapeutics aimed at restoring cell cycle control.
• Enables research on differentiation and development via E2F regulation.
What Happens During Rb-E2F complex?
Assembly of the Rb-E2F Repressor Complex
In simple terms: Rb and E2F proteins join together to form a brake on cell division.
The Rb-E2F complex assembles when a Retinoblastoma family protein (RB1, RBL1, or RBL2) binds to a heterodimeric E2F transcription factor. This interaction is regulated by phosphorylation of Rb family proteins; hypophosphorylated Rb binds E2F, while hyperphosphorylation by CDKs releases E2F to activate transcription. The assembly of this complex is a key step in the p53-p21-RB signaling pathway that halts cell cycle progression. The complex is related to the DREAM/MuvB complex, which also represses cell cycle genes.
Transcriptional Repression of E2F Target Genes
In simple terms: Once formed, the complex sits on DNA and turns off genes needed for cell division.
The Rb-E2F complex binds to E2F consensus sites in the promoters of target genes and represses their transcription. This repression requires the recruitment of co-repressors such as histone deacetylases (HDACs) and Mediator subunits. For example, MED13L is a Mediator subunit involved in Rb/E2F-induced growth arrest. HDACs are also recruited by Rb-E2F complexes to repress interferon-induced genes during adenovirus infection. This transcriptional repression prevents cells from entering S phase and maintains cell cycle arrest.
Regulation by Phosphorylation and CDK Activity
In simple terms: Chemical tags on Rb decide whether the brake is on or off.
The activity of the Rb-E2F complex is controlled by phosphorylation. Cyclin-dependent kinases (CDKs) phosphorylate Rb family proteins, causing them to release E2F and allowing transcription of E2F target genes. Conversely, CDK inhibitors such as p21 and p16 keep Rb hypophosphorylated, promoting Rb-E2F complex formation and cell cycle arrest. This regulatory circuit is a core component of the p53-p21-RB signaling axis. The balance between phosphorylated and unphosphorylated Rb determines whether cells proliferate or arrest.
Role in Senescence and Growth Arrest
In simple terms: The complex helps cells enter a permanent state of no division called senescence.
The Rb-E2F complex is a key mediator of cellular senescence. In senescent cells, transcriptional repression of mitotic and DNA repair genes occurs through the p53-p16/RB-E2F-DREAM complex. This repression contributes to the stable growth arrest characteristic of senescence. The complex also mediates Rb/E2F-induced growth arrest in response to various stimuli, involving Mediator subunit MED13L. Thus, the Rb-E2F complex integrates signals from p53 and p16 to enforce long-term cell cycle exit.
Interaction with Viral Proteins and Pathogens
In simple terms: Some viruses target this complex to keep infected cells alive.
Viruses have evolved mechanisms to manipulate the Rb-E2F complex. For example, Rb-E2F-HDAC repressor complexes control interferon-induced repression of adenovirus to promote persistent infection. This highlights how the complex can be co-opted by pathogens to modulate host cell cycle and immune responses. Understanding these interactions may inform antiviral strategies.
Key Genes Involved in GO:0035189 Rb-E2F complex
The Rb-E2F complex comprises E2F transcription factors, DP dimerization partners, and Retinoblastoma family proteins, along with associated co-repressors.
| Gene | Major Role | Research Relevance |
|---|---|---|
| RB1 | Retinoblastoma protein, binds E2F to repress transcription | Tumor suppressor, mutated in retinoblastoma and many cancers |
| RBL1 | p107, Rb family member, forms repressor complexes with E2F | Regulates cell cycle and differentiation |
| RBL2 | p130, Rb family member, component of DREAM complex | Key in quiescence and senescence |
| E2F1 | E2F transcription factor, activates or represses target genes | Regulates proliferation and apoptosis |
| E2F2 | E2F transcription factor | Cell cycle regulation |
| E2F3 | E2F transcription factor | Cell cycle regulation |
| E2F4 | E2F transcription factor, primarily repressive | Forms repressor complexes with Rb and DREAM |
| E2F5 | E2F transcription factor, repressive | Cell cycle regulation |
| TFDP1 | DP1, dimerization partner for E2F | Essential for E2F DNA binding |
| TFDP2 | DP2, dimerization partner for E2F | Essential for E2F DNA binding |
| HDAC1 | Histone deacetylase, recruited by Rb-E2F for repression | Chromatin modification in repression |
| HDAC2 | Histone deacetylase, co-repressor | Chromatin modification in repression |
| MED13L | Mediator subunit, involved in Rb/E2F-induced growth arrest | Links Mediator to cell cycle arrest |
| CDK4 | Cyclin-dependent kinase, phosphorylates Rb | Regulates Rb-E2F interaction |
| CDK6 | Cyclin-dependent kinase, phosphorylates Rb | Regulates Rb-E2F interaction |
| CCND1 | Cyclin D1, activates CDK4/6 to phosphorylate Rb | Drives cell cycle progression |
| CDKN1A | p21, CDK inhibitor, stabilizes Rb-E2F complexes | Mediates p53-induced arrest |
| CDKN2A | p16, CDK inhibitor, promotes Rb hypophosphorylation | Senescence and tumor suppression |
How Is Rb-E2F complex Regulated?
The Rb-E2F complex is regulated primarily by phosphorylation of Rb family proteins by CDK-cyclin complexes. Hypophosphorylated Rb binds E2F to repress transcription, while hyperphosphorylation by CDK4/6-cyclin D and CDK2-cyclin E releases E2F, allowing gene activation. CDK inhibitors such as p21 (CDKN1A) and p16 (CDKN2A) maintain Rb in its hypophosphorylated state, promoting complex formation and cell cycle arrest [1,6]. Additionally, the complex interacts with chromatin modifiers like HDACs and Mediator subunits, which modulate its repressive activity [5,7]. The DREAM/MuvB complex, which shares components with Rb-E2F, provides an additional layer of regulation during the cell cycle.
Rb-E2F complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| RB1 | Retinoblastoma, osteosarcoma, many cancers | RB1 knockout cell lines, knock-in of patient mutations |
| CDKN2A | Melanoma, pancreatic cancer, senescence | CDKN2A knockout or point mutation models |
| CCND1 | Breast cancer, lymphoma | CCND1 overexpression models |
| E2F1 | Cancer, apoptosis | E2F1 knockout or overexpression |
| MED13L | Growth arrest, developmental disorders | MED13L knockout or knock-in |
Cancer
Dysregulation of the Rb-E2F complex is a common event in cancer. Loss of RB1 function or hyperactivation of CDKs leads to constitutive E2F activity and uncontrolled proliferation. In melanocytic systems, Rb/E2F acts as a two-edged sword, with roles in both tumor suppression and oncogenesis depending on context. Targeting the Rb-E2F axis is a therapeutic strategy in multiple cancers.
Cellular Senescence and Aging
The Rb-E2F complex is a key mediator of cellular senescence. In senescent cells, transcriptional repression of mitotic and DNA repair genes occurs through the p53-p16/RB-E2F-DREAM complex. This repression contributes to the stable growth arrest of senescence, which is relevant to aging and age-related diseases.
Viral Infection
Viruses can manipulate the Rb-E2F complex to promote persistent infection. For example, Rb-E2F-HDAC repressor complexes control interferon-induced repression of adenovirus, allowing the virus to evade immune responses. This highlights the complex as a target for antiviral research.
From Rb-E2F complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of RB1 activate E2F target genes? | RB1 knockout cell line |
| Does a specific point mutation in RB1 disrupt E2F binding? | RB1 point-mutation knock-in |
| Can tagged E2F4 be used to map genomic binding sites? | Tagged knock-in of E2F4 |
| Does overexpression of cyclin D1 overcome Rb-E2F repression? | CCND1 overexpression |
| Is MED13L required for Rb/E2F-induced growth arrest? | MED13L knockout |
| Does p16 induction cause Rb-E2F complex formation? | CDKN2A overexpression or knock-in |
How to Study the Rb-E2F complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Gene expression changes | Identify E2F target genes repressed by Rb-E2F |
| ChIP-seq | Genomic binding sites | Map E2F and Rb occupancy |
| Co-IP/MS | Protein interactions | Discover complex components and co-repressors |
| Flow cytometry | Cell cycle distribution | Assess proliferation and arrest |
| Western blot | Protein levels and phosphorylation | Monitor Rb phosphorylation status |
| Luciferase reporter | Transcriptional activity | Measure E2F-dependent promoter activity |
| CRISPR screening | Gene essentiality and interactions | Identify modifiers of Rb-E2F function |
Transcriptomics (RNA-seq)
RNA sequencing measures global changes in gene expression upon perturbation of Rb-E2F components. It can identify E2F target genes whose repression depends on the complex.
Chromatin Immunoprecipitation (ChIP-seq)
ChIP-seq using antibodies against E2F or Rb family proteins maps their binding sites across the genome, revealing direct targets of the Rb-E2F complex.
Proteomics and Co-immunoprecipitation
Co-immunoprecipitation coupled with mass spectrometry identifies protein-protein interactions within the Rb-E2F complex and its associated co-repressors.
Cell Cycle Analysis
Flow cytometry and proliferation assays assess the functional impact of Rb-E2F complex perturbations on cell cycle progression and growth arrest.
How CRISPR Can Be Used to Study GO:0035189 Rb-E2F complex
Knockout
CRISPR knockout of RB1, E2F genes, or co-repressors such as MED13L can reveal their requirement for Rb-E2F complex function. For example, RB1 knockout leads to constitutive E2F activity and deregulated cell cycle progression. Knockout of MED13L impairs Rb/E2F-induced growth arrest.
Point Mutation
Point mutations in RB1 that disrupt E2F binding or in E2F DNA-binding domains can be introduced to dissect specific interactions. Such models help determine which residues are critical for complex assembly and repression.
Knock-in
Knock-in of tagged versions of E2F or Rb proteins (e.g., GFP or HA tags) enables ChIP-seq and proteomic studies to map binding sites and interactors in a physiological context.
Overexpression
Overexpression of cyclin D1 or CDK4/6 can hyperphosphorylate Rb and disrupt the Rb-E2F complex, mimicking cancer-associated changes. Conversely, overexpression of p16 or p21 stabilizes the complex and induces arrest.
How EDITGENE Supports Rb-E2F complex Research
Researchers studying Rb-E2F complex-related genes often need to determine whether a candidate gene is causally involved in cell cycle regulation, senescence, or cancer. EDITGENE provides a comprehensive suite of CRISPR services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for Rb-E2F complex research.
Frequently Asked Questions About Rb-E2F complex
What is the Rb-E2F complex?
The Rb-E2F complex (GO:0035189) is a multiprotein complex containing a heterodimeric E2F transcription factor and a Retinoblastoma (Rb) family member that represses transcription of E2F-regulated genes to regulate cell cycle progression.
What genes are involved in the Rb-E2F complex?
Key genes include RB1, RBL1, RBL2, E2F1-5, TFDP1/2, and co-repressors such as HDAC1/2 and MED13L [1,5,7].
How does the Rb-E2F complex regulate the cell cycle?
It binds to E2F sites and represses transcription of genes required for S phase, preventing cell cycle progression until phosphorylation of Rb releases E2F.
What is the difference between Rb-E2F and DREAM complex?
The DREAM/MuvB complex shares components with Rb-E2F but includes additional proteins like LIN54 and RBL2, and both coordinate cell cycle gene expression.
What diseases are associated with Rb-E2F complex dysfunction?
Dysregulation is linked to cancer, senescence, and viral persistence, including retinoblastoma and melanoma [1,4,6,7].
How can I study the Rb-E2F complex using CRISPR?
CRISPR knockout, point mutation, knock-in, and overexpression models allow functional dissection of complex components and their roles in cell cycle and disease [1,5].
What methods are used to analyze Rb-E2F complex activity?
Common methods include RNA-seq, ChIP-seq, co-immunoprecipitation, flow cytometry, and luciferase reporter assays [2,5,8].
Is the Rb-E2F complex involved in senescence?
Yes, it mediates transcriptional repression of mitotic and DNA repair genes during senescence through the p53-p16/RB-E2F-DREAM complex.
Can viruses manipulate the Rb-E2F complex?
Yes, adenovirus can co-opt Rb-E2F-HDAC repressor complexes to repress interferon-induced genes and promote persistent infection.
What are the therapeutic implications of targeting the Rb-E2F complex?
Restoring Rb-E2F repression or inhibiting CDKs that phosphorylate Rb are strategies in cancer therapy.
Conclusion
The Rb-E2F complex (GO:0035189) is a central transcriptional repressor module that controls cell cycle progression, senescence, and responses to viral infection. Its dysregulation is a common theme in cancer and other diseases, making it a prime target for basic and translational research. By leveraging CRISPR-based models and multi-omics methods, researchers can dissect the precise roles of its components and identify new therapeutic opportunities.
References
- 1. Engeland K. 2022. Cell cycle regulation: p53-p21-RB signaling.. Cell Death Differ 29(5):946-960 PMID: 35361964
- 2. Fischer M et al.. 2022. Coordinating gene expression during the cell cycle.. Trends Biochem Sci 47(12):1009-1022 PMID: 35835684
- 4. Halaban R. 2005. Rb/E2F: a two-edged sword in the melanocytic system.. Cancer Metastasis Rev 24(2):339-56 PMID: 15986142
- 5. Angus SP et al.. 2012. A role for Mediator complex subunit MED13L in Rb/E2F-induced growth arrest.. Oncogene 31(44):4709-17 PMID: 22249253
- 6. Kandhaya-Pillai R et al.. 2023. Key elements of cellular senescence involve transcriptional repression of mitotic and DNA repair genes through the p53-p16/RB-E2F-DREAM complex.. Aging (Albany NY) 15(10):4012-4034 PMID: 37219418
- 7. Snaider S et al.. 2022. Rb-E2F-HDAC Repressor Complexes Control Interferon-Induced Repression of Adenovirus To Promote Persistent Infection.. J Virol 96(11):e0044222 PMID: 35546119
- 8. Fischer M et al.. 2017. Cell cycle transcription control: DREAM/MuvB and RB-E2F complexes.. Crit Rev Biochem Mol Biol 52(6):638-662 PMID: 28799433
